Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitapas C liposomal 1000
- Development stage
- Unknown
- Lead developer
- Pascoe Naturmedizin
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Oral
01
Overview
Vitapas C liposomal 1000 is a vegan nutritional supplement developed by Pascoe Pharmazeutische Präparate in collaboration with scientists at the University of Marburg. The product utilizes a proprietary liposomal delivery technology that encapsulates L-ascorbic acid (vitamin C) in sunflower lecithin-based liposomes. This formulation is designed to mimic cell membranes, thereby enhancing the oral bioavailability and intestinal absorption of vitamin C compared to conventional supplement forms. Each daily dose of three capsules provides 1,000 mg of vitamin C, which serves as a potent antioxidant and an essential cofactor for various biological processes. It is marketed for nutritional supplementation, supporting immune system function, protecting cells from oxidative stress, aiding collagen formation, and reducing fatigue.
- Brand names
- Vitapas C liposomal 1000
- Other names
- Vitapas C liposomalliposomal Vitamin C
02
Targets
LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)P4H (Prolyl 4-hydroxylase subunit alpha-3)
Beyond the preview
Go deeper on Vitapas C liposomal 1000.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitapas C liposomal 1000.